🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 39 of 78

  1. US 8961989

    Methods for producing an immune response to tuberculosis

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8962297

    Bacteriophage lytic enzymes as alternative antimicrobials

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8961955

    Maintenance and propagation of mesenchymal stem cells

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8961975

    Monoclonal antibodies that neutralize anthrax toxins

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8957188

    Antibodies that bind GalNAc1-3Gal, pharmaceutical compositions and methods of using same

    Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8957192

    Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1

    Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8957015

    Tumor suppressor gene p47ING3

    Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8951793

    Method of making an isolated population of FOXP3+ regulatory T cells

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8951527

    Radioprotectants targeting thrombospondin-1 and CD47

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8951501

    Noninvasive thermometry monitoring system

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8946398

    Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

    Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8946382

    Apelin peptides and methods of use

    Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8946243

    Compounds and methods for the treatment of viral infection

    Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8946291

    Compositions and methods for treating pigmentary conditions and melanoma

    Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8940535

    Stem cell culture medium and method of using said medium and the cells

    Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8940700

    E-selectin compositions and use thereof for inducing E-selectin tolerance

    Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8940690

    Synthetic conjugates and uses thereof

    Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8937067

    Activators of human pyruvate kinase

    Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8936787

    Peptides promoting lipid efflux

    Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8936792

    Pseudomonas exotoxin a with reduced immunogenicity

    Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8933041

    System for treating and preventing breast cancer

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8927030

    Use of nitrite salts for the treatment of cardiovascular conditions

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8927495

    Use of GnRH and analogs thereof for the prevention and treatment of pet ferret adrenocortical hyperplasia

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8926986

    Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8926987

    Replication-competent adenoviral vectors

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8927269

    Avian adenoassociated virus and uses thereof

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8927725

    Thio compounds

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8920807

    Vault complexes for cytokine delivery

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8921050

    Methods of diagnosing renal cell carcinoma

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8921323

    Methods and compositions for modulating BCL-2 family polypeptides

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8921340

    Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8921071

    Targeting poly-gamma-glutamic acid to treat Staphylococcus epidermidis and related infections

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8921097

    Methods for expression and purification of immunotoxins

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8916159

    Selenocysteine mediated hybrid antibody molecules

    Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8916596

    Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor

    Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8916556

    Pharmaceutical formulations comprising neurotrophin mimetics

    Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8916570

    A3 adenosine receptor agonists and antagonists

    Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8916172

    MVA expressing modified HIV envelope, gag, and pol genes

    Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8916175

    Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection

    Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8912214

    Use of Chk2 kinase inhibitors for cancer treatment

    Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8912146

    Derivatives of APF and methods of use

    Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8911728

    High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins

    Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8912316

    Compositions and methods for inhibiting expression of CD45 gene

    Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8911742

    Transcutaneous immunization without heterologous adjuvant

    Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8906384

    Antiviral activity of bovine type III interferon against foot-and-mouth disease virus

    Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8905913

    Method and composition for synchronizing time of insemination

    Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8907060

    Mutated Pseudomonas exotoxins with reduced antigenicity

    Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8906358

    Leishmania challenge model

    Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.